TipRanks
AK Medical Holdings Ltd. (HK:1789)
:1789
Hong Kong Market
1789
AK Medical Holdings Ltd.
RESEARCH TOOLSreports
Want to see HK:1789 full AI Analyst Report?

AK Medical Holdings Ltd. (1789) Ratios

1 Followers

AK Medical Holdings Ltd. Ratios

HK:1789's free cash flow for Q2 2026 was ¥0.64. For the 2026 fiscal year, HK:1789's free cash flow was decreased by ¥ and operating cash flow was ¥0.29. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.62 4.10 3.65 3.96 4.73
Quick Ratio
 2.96 3.41 2.83 2.77 3.81
Cash Ratio
 1.51 0.57 0.59 0.66 1.43
Solvency Ratio
 0.62 0.59 0.49 0.45 0.54
Operating Cash Flow Ratio
 0.57 0.64 0.76 0.07 0.56
Short-Term Operating Cash Flow Coverage
 429.12 5.82 7.46 1.59 0.00
Net Current Asset Value
¥ 1.80B¥ 1.95B¥ 1.48B¥ 1.36B¥ 1.53B
Leverage Ratios
Debt-to-Assets Ratio
 0.02 0.04 0.03 0.03 0.01
Debt-to-Equity Ratio
 0.03 0.05 0.04 0.04 0.02
Debt-to-Capital Ratio
 0.03 0.05 0.04 0.03 0.02
Long-Term Debt-to-Capital Ratio
 <0.01 <0.01 <0.01 0.01 0.00
Financial Leverage Ratio
 1.29 1.26 1.26 1.26 1.24
Debt Service Coverage Ratio
 135.25 5.67 5.31 12.10 132.17
Interest Coverage Ratio
 166.39 127.13 325.87 164.32 101.19
Debt to Market Cap
 <0.01 0.01 0.02 <0.01 0.00
Interest Debt Per Share
 0.07 0.13 0.09 0.08 0.04
Net Debt to EBITDA
 -1.86 -0.48 -0.68 -0.76 -1.82
Profitability Margins
Gross Profit Margin
62.75%60.54%60.03%61.66%60.49%
EBIT Margin
27.49%25.22%22.34%21.25%23.05%
EBITDA Margin
34.65%32.43%27.60%29.56%30.69%
Operating Profit Margin
27.49%25.22%22.34%19.33%20.91%
Pretax Profit Margin
28.21%26.64%23.75%21.13%22.84%
Net Profit Margin
24.16%22.87%20.35%16.65%19.46%
Continuous Operations Profit Margin
24.16%22.87%20.35%16.65%19.46%
Net Income Per EBT
85.66%85.85%85.65%78.79%85.22%
EBT Per EBIT
102.62%105.64%106.33%109.28%109.23%
Return on Assets (ROA)
10.59%9.25%8.21%6.06%7.38%
Return on Equity (ROE)
13.24%11.64%10.38%7.61%9.13%
Return on Capital Employed (ROCE)
15.11%12.44%10.98%8.44%9.41%
Return on Invested Capital (ROIC)
12.92%10.41%9.16%6.56%7.97%
Return on Tangible Assets
11.21%9.77%8.73%6.50%8.17%
Earnings Yield
8.48%5.92%5.39%2.84%2.14%
Efficiency Ratios
Receivables Turnover
 1.99 2.13 2.33 1.99 1.93
Payables Turnover
 3.77 4.21 3.54 2.40 2.68
Inventory Turnover
 1.23 1.27 1.10 0.70 1.03
Fixed Asset Turnover
 2.25 2.12 1.97 2.15 2.87
Asset Turnover
 0.44 0.40 0.40 0.36 0.38
Working Capital Turnover Ratio
 0.79 0.82 0.88 0.70 0.68
Cash Conversion Cycle
 383.49 370.97 384.60 549.59 406.27
Days of Sales Outstanding
 183.65 170.99 156.34 183.54 189.21
Days of Inventory Outstanding
 296.76 286.62 331.42 518.30 353.34
Days of Payables Outstanding
 96.92 86.64 103.16 152.24 136.27
Operating Cycle
 480.41 457.61 487.75 701.84 542.54
Cash Flow Ratios
Operating Cash Flow Per Share
 0.37 0.37 0.40 0.03 0.22
Free Cash Flow Per Share
 0.29 0.28 0.26 -0.14 0.11
CapEx Per Share
 0.07 0.09 0.15 0.17 0.11
Free Cash Flow to Operating Cash Flow
 0.81 0.75 0.64 -4.78 0.50
Dividend Paid and CapEx Coverage Ratio
 2.69 2.40 2.17 0.13 1.67
Capital Expenditure Coverage Ratio
 5.14 4.07 2.78 0.17 2.00
Operating Cash Flow Coverage Ratio
 5.20 2.89 4.54 0.40 6.26
Operating Cash Flow to Sales Ratio
 0.26 0.28 0.34 0.03 0.23
Free Cash Flow Yield
7.70%5.52%5.69%-2.53%1.26%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 11.69 17.07 18.56 35.22 46.83
Price-to-Sales (P/S) Ratio
 2.74 3.87 3.78 5.86 9.11
Price-to-Book (P/B) Ratio
 1.61 1.97 1.93 2.68 4.27
Price-to-Free Cash Flow (P/FCF) Ratio
 12.99 18.13 17.58 -39.56 79.11
Price-to-Operating Cash Flow Ratio
 10.86 13.67 11.27 189.03 39.47
Price-to-Earnings Growth (PEG) Ratio
 0.38 0.85 0.33 -3.17 0.40
Enterprise Value Multiple
 6.06 11.44 13.00 19.07 27.88
Enterprise Value
 3.26B 5.50B 4.83B 6.17B 9.00B
EV to EBITDA
 6.06 11.44 13.00 19.07 27.88
EV to Sales
 2.10 3.71 3.59 5.64 8.56
EV to Free Cash Flow
 9.94 17.40 16.71 -38.04 74.27
EV to Operating Cash Flow
 8.00 13.12 10.71 181.75 37.06
Tangible Book Value Per Share
 2.30 2.43 2.19 1.92 1.78
Shareholders’ Equity Per Share
 2.48 2.60 2.36 2.10 2.02
Tax and Other Ratios
Effective Tax Rate
 0.14 0.14 0.14 0.21 0.15
Revenue Per Share
 1.40 1.32 1.21 0.96 0.95
Net Income Per Share
 0.34 0.30 0.25 0.16 0.18
Tax Burden
 0.86 0.86 0.86 0.79 0.85
Interest Burden
 1.03 1.06 1.06 0.99 0.99
Research & Development to Revenue
 0.09 0.10 0.10 0.13 0.11
SG&A to Revenue
 0.27 0.28 0.29 0.12 0.11
Stock-Based Compensation to Revenue
 0.00 0.00 <0.01 <0.01 <0.01
Income Quality
 1.09 1.27 1.41 0.15 1.01
Currency in CNY